Reclassification of prostate cancer risk using sequentially identified SNPs: Results from the REDUCE trial

BACKGROUND: While the clinical validity of risk-associated single nucleotide polymorphisms (SNPs) for assessment of disease susceptibility has been consistently established, risk reclassification from increasing numbers of implicated risk-associated SNPs raises concern that it is premature for clini...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Prostate
Main Authors: Chen, Haitao, Na, Rong, Packiam, Vignesh T., Conran, Carly A., Jiang, Deke, Tao, Sha, Yu, Hongjie, Lin, Xiaoling, Meng, Wei, Zheng, S. Lilly, Brendler, Charles B., Helfand, Brian T., Xu, Jianfeng
Formato: Artigo
Idioma:Inglês
Publicado em: 2017
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6949015/
https://ncbi.nlm.nih.gov/pubmed/28670847
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/pros.23369
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados